Fact.MR – A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, the global biobanking market size would advance at a healthy CAGR of 7% during the forecast period.
Sales of Equipment for Storing Biospecimen would surge, and temperature control systems are projected to cross the US$ 1 Bn mark by 2027
Fact.MR’s latest report on Biobanking market offers unbiased industry analysis for the period between 2020 and 2027. The study divulges exclusive information about existing opportunities and emerging trends across leading segments in terms of product, usage and end user. It also highlights various strategies employed by key manufacturers to gain edge in the market.
Fact.MR – A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, the global biobanking market size would advance at a healthy CAGR of 7% during the forecast period.
Manual storage systems are projected to register 64% share in the biobanking market by 2027, given their low capital requisites. However, players in the biobanking equipment market are increasingly striving to transform the landscape through the introduction of advanced software, which helps in reducing manual errors. Automated storage systems offer high precision and time-efficiency, which is likely to significantly increase their adoption in the foreseeable future. Automated storage systems are projected to register a CAGR of 7% during the forecast period (2020-2027).
A recent study published by Fact.MR examines the growth potential of the biobanking market, and projects CAGR to be above average during the forecast period.
Want A Detailed Understanding of Market Functioning? Request for a Sample Here
https://www.factmr.com/connectus/sample?flag=S&rep_id=4438
Key Highlights of Biobanking Market Study
• China shows strong growth prospects in the biobanking market with an estimated CAGR of around 8.6% during 2020-2027. The country has three biobanks - China Kadoorie Biobank, Zhongnan Biobank, and Cancer Centre Tissue Bank, which work towards investigating the genetic causes of infectious and chronic diseases.
• Demand for biobanking software and services is growing at a relatively high rate as compared to equipment and consumables, as these products are used to minimise errors and increase the accuracy of sample data. Biobanking software and services are projected to be deployed at the highest CAGR of around 7.5% in the biobanking market sales during the forecast period.
• Blood products are expected to remain key biospecimen in the biobanking market, exceeding the storage of other samples, as demand for blood transfusion and DNA is increasing for the diagnosis and treatment of chronic diseases.
• The set-up cost of a biobank can vary from US$ 3 Mn to US$ 6 Mn. Sample handling, storage management, human resources, instruments, consumables, and software further add up to the already high cost of biobanking, which is likely to act as a barrier to the growth of the biobanking market.
A senior research analyst at Fact.MR opines,
“Though the application of biospecimen for the development of therapeutics is growing, there will be a notable spurt in the adoption rate of bio-samples for clinical diagnosis to understand cell structure.”
Product Innovation within the Boundaries of Environmental Sustainability
Product innovation is a key strategy adopted by players in the biobanking market. As biobanking of biospecimen requires freezing temperature for storage, leading players are, in turn, making a shift towards offering products with the least possible carbon footprints. Thermo Fisher Scientific, Inc. is an ideal company exhibiting this strategic move. In 2017, the company announced that it had received the ENERGY STAR certification for its temperature freezers from the U.S. Environmental Protection Agency to reduce energy consumption, while ensuring the protection of biospecimen.
Players operating in other tiers seek expansion in the fragmented biobanking market through collaborations, acquisitions, and partnerships, to achieve better exposure of their products.
To gain in-depth insights on Biobanking Market, request methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4438
High Operational Cost Concerns Portend Limited Adoption of Biobank Products
According to the study, technological advancements present a crucial challenge associated with cost. Integration of advanced technology means high cost of equipment and consumables, which, in turn, increases the operational costs of biobanks.
For instance, in France and the Netherlands, the annual operational cost of a biobank products ranges from US$ 220,000 to US$ 880,000. Besides this, cost associated with infrastructure, equipment, human resources, and supplies further make it an expensive working model. The high operational cost of biobanks reflects on the increasing price of storage for end users, which is leading to a low adoption rate of biobanks.
Target Audience for this Report:
- Biobanking associations
- Research & consulting firms
- Distributors of research products
- Contract manufacturers of biobanking equipment and consumables
- Research institutes and clinical research organizations (CROs)
- Venture capitalists
- Government associations
Competitive Landscape
Key players operating in the biobanking market include Thermo Fisher Scientific, Inc., Tecan Trading AG, PHC Holdings Corporation (Panasonic Healthcare), Merck KGaA, Hamilton Company, Brooks Automation, Inc., Chart Industries, Inc., Greiner AG, VWR International, LLC, and QIAGEN N.V.
Key Questions Covered in the Biobanking Market Outlook Report
- The report offers insight into Biobanking demand outlook for 2020-2027
- The market study also highlights projected sales growth for Biobanking market between 2020 and 2027
- Biobanking market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
- Biobanking market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain –
Patient Positioning System Market Insights- Patient positioning system demand has increased in recent years and is likely to grow somewhat over the next ten years. Patient positioning system demand is being driven by an increase in the incidence of chronic diseases, an increase in patient hospitalization, a growing geriatric population, technical improvements, and the necessity for technologically equipped healthcare centers. In the new advanced healthcare infrastructure that is being bolstered, rising healthcare expenditure in most nations is predicted to be tremendously beneficial in terms of sales of patient positioning systems.
Specialty Medical Chairs Market Analysis- Over the projected period, the expanding geriatric population is expected to increase demand for specialty medical chairs. Furthermore, the advent of technologically improved and fully automated medical chairs is expected to provide attractive growth possibilities for the market. Patients with end-stage renal disease (ESRD) should receive the same level of care and treatment at home as they do in hospitals, according to ESRD legislation, encouraging product usage in homecare. These factors are projected to contribute to the market’s growth in the coming years.
Medical Beds Market Forecast- In the next 10 years, demand for hospital beds is likely to increase as the global focus on healthcare strengthens. Healthcare infrastructure is rapidly evolving around the world, which may be ascribed to the industry’s increased technological proliferation as well as the growing demand for healthcare services. The aforementioned factors are projected to boost the hospital beds and surgical beds markets at the same time.
Medical beds are utilized in a variety of settings, including rehabilitation centers and elderly care facilities. Medical beds are projected to be used more frequently in aged care homes.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000’s trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR